Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression

A large health-record analysis found glucosamine use associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest it may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, but clinical trials are needed to determine actual harm.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.